Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. Long Term Debt 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual long term debt history from 2020 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Corbus Pharmaceuticals Holdings, Inc. long term debt as of December 31, 2022: 21.6M, a 1.89% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2022 were 21.6M, a 1.89% increase from 2021.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2021 were 21.2M, a 0.00% increase from 2020.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2020 were 21.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Corbus Pharmaceuticals Holdings, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $22 |
| 2021 | $21 |
| 2020 | $21 |
Corbus Pharmaceuticals Holdings, Inc. Long Term Debt — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's long term debt history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s long term debt by year and by quarter, including the growth rate.